Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Near-infrared photosensitizer-induced cytotoxicity is a mechanism employed in photodynamic therapy (PDT) where photosensitizing agents, activated by NIR light, produce cytotoxic reactive oxygen species (ROS) that damage and kill cells. The specificity of this approach can be enhanced by conjugating photosensitizers to targeting moieties like antibodies. The type of cell death induced (apoptosis or necrosis) depends on the photosensitizer, its localization, and the ROS concentration. Key considerations include the photosensitizer's absorption wavelength, photostability, dark toxicity, ROS generation efficiency, and tumor selectivity.
Upon irradiation with near-infrared (NIR) light, photosensitizers generate reactive oxygen species (ROS), leading to oxidative damage and subsequent cell death (apoptosis or necrosis).
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Near-Infrared Photosensitizer-Induced Cytotoxicity (NIR-PDT).